TRIM21 and systemic sclerosis: Given the finding of anti-Ro52 antibody enrichment in the BAL fluid of SSc-ILD patients who were seropositive for anti-Ro52, we next examined whether anti-Ro52 measured in the sera was associated with progression of SSc-ILD.